[1]
Ay, N. et al. 2021. Posttransplant de novo donor specific HLA antibody monitoring and clinical outcomes: a single-center experience. The European Research Journal. 7, 3 (May 2021), 304–311. DOI:https://doi.org/10.18621/eurj.732625.